903 / 1498
U Modena Experience
Results:
•
MVA: in pts in
CR/PR
RT was associated with significantly
lower event rates
(HR, 0.33, 95% CI 0.11-0.97)
and in pts with
CR
to R-CHOP
(HR, 0.24, 95% CI 0.06-0.92)
Conclusions:
•
The role of RT in the treatment of DLBCL, at either early or
advanced stages, is still unclear.
•
Prospective studies needed
Marcheselli et al. Leuk Lymphoma, 2011